Edison Explains Psychedelics
Edison Group looks at the ongoing revolution of hallucinogenic drug research. Edison’s Sean Conroy states that recent preliminary...
Edison Explains Psychedelics
Esker Q3 Revenue Update
XP Power Q3 Trading Update
Standard Life UK Smaller Companies Trust
Greggs Medium-term Growth Ambition Quantified
Datatec H122 Trading Update
Baillie Gifford US Growth Trust
September Edison Healthcare Insight
Cryptocurrency Series Part 7
Datatec Strong H122 Forecast